What is Kinomica?
Founded in 2016 and based in Macclesfield, England, Kinomica operates at the intersection of data science and diagnostics, with a specialized focus on proteomic analysis and cell signaling. The company leverages advanced computational techniques to interpret complex biological data, aiming to provide novel insights and diagnostic tools for various applications within the life sciences sector. Its expertise in deciphering cell signaling pathways positions it as a key player in the growing field of precision medicine and biopharmaceutical research.
How much funding has Kinomica raised?
Kinomica has raised a total of $5.2M across 1 funding round:
Unspecified
$5.2M
Unspecified (2020): $5.2M with participation from Longwall Ventures, Alderley Park, Puffin Point, BGF Ventures, and BioCity Group Limited
Key Investors in Kinomica
Longwall Ventures
Longwall Ventures is a venture capital firm that specializes in investing in early-stage deeptech businesses, particularly those leveraging UK scientific research and development expertise to address global challenges.
BGF Ventures
BGF is a prominent equity investor in the UK and Ireland, providing long-term, minority investment and value creation support to growing companies, with a focus on scaling up early-stage SMEs and private companies.
Alderley Park
Alderley Park is a significant hub for life sciences and technology companies, likely providing strategic support and investment to businesses within its ecosystem.
What's next for Kinomica?
The recent major strategic investment in Kinomica signals a strong confidence from its backers in the company's growth trajectory and technological innovation. This capital infusion is expected to accelerate the development and commercialization of its proteomic-data science solutions, potentially expanding its market reach and enhancing its diagnostic capabilities. The company is likely to focus on scaling its operations, further refining its analytical platforms, and forging strategic partnerships to solidify its position in the competitive diagnostics and life sciences landscape.
See full Kinomica company page
